Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03445325

Ligand	Ligand name	Chain	PDB	Tanimoto
B3Y	(3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID	A	3HF0	0.73
B3Y	(3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID	A	2OXK	0.73
B3Y	(3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID	A,B,C	2OXJ	0.73
H24	(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one	A	2VA6	0.71
IYG	N-ALPHA-ACETYL-3,5-DIIODOTYROSYLGLYCINE	A	1OPM	0.73
DTY	D-TYROSINE	A	1C4B	0.71
DTY	D-TYROSINE	A,L	1ZEA	0.71
DTY	D-TYROSINE	A,B,C,D,E,F,G,H	1OF6	0.71
DTY	D-TYROSINE	A,B	1UNO	0.71
DTY	D-TYROSINE	A	2IGZ	0.71
DTY	D-TYROSINE	A,B,C,H,K,L	2R5D	0.71
DTY	D-TYROSINE	A,B	2Q33	0.71
DTY	D-TYROSINE	H,S	2H9E	0.71
DTY	D-TYROSINE	A,B,C,H,K,L	2R5B	0.71
DTY	D-TYROSINE	A	2IH0	0.71
DTY	D-TYROSINE	A	1D7T	0.71
DTY	D-TYROSINE	A,B	1XA0	0.71
Y13	(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE	A	2EW6	0.7
0E4	N-acetyl-L-tyrosyl-L-valyl-L-alanyl-L-aspartic acid	B,D	3GJS	0.72
ZYA	BENZOYL-TYROSINE-ALANINE-METHYL KETONE	A	1AIM	0.72
TYB	TYROSINAL	A,B	1KDZ	0.71
TYB	TYROSINAL	A	1Q11	0.71
TYB	TYROSINAL	A,B	2J5B	0.71
TYB	TYROSINAL	A,I	1GA4	0.71
TYB	TYROSINAL	A,B,C	1NLU	0.71
TYB	TYROSINAL	A,B	1KE1	0.71
TYB	TYROSINAL	A,B	1H3F	0.71
TYB	TYROSINAL	A,B	1H3E	0.71
CJO	[(2R,4R)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-(4-hydroxybenzyl)-5-oxoimidazolidin-1-yl]acetic acid	A	2QT2	0.75
BJH	1(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID	A	1ERQ	0.73
BBB	1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE	A,B,C,D,E,F	1U1G	0.71
3XH	3-Hydroxyhippuric acid	A	3E9K	0.7
BJI	1(R)-1-ACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID	A	1ERM	0.71
SD2	N-(SULFANYLACETYL)TYROSYLPROLYLMETHIONINAMIDE	A,B	1PWQ	0.71
SGI	3-(4-hydroxyphenyl)propanamide	A,B	2R9K	0.76
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B	2AH8	0.75
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B,C,D	1HCJ	0.75
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B,C,D	1W7S	0.75
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B,C,D	1W7T	0.75
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B	2AHA	0.75
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A	1EME	0.75
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B	1KP5	0.75
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A	1EMM	0.75
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A	1EML	0.75
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B,C,D	1W7U	0.75
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B,C,D	1EMC	0.75
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A	2HPW	0.75
TYP	CYCLO-(L-TYROSINE-L-PROLINE) INHIBITOR	A,B	1W1Y	0.76
3QC	(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE	A,B	2FME	0.72
YBY	N-{[(1S)-1-carboxy-2-(4-hydroxy-3-iodophenyl)ethyl]carbamoyl}-L-glutamic acid	A	3D7F	0.74
HQQ	5-METHYL-5-(4-PHENOXY-PHENYL)-PYRIMIDINE-2,4,6-TRIONE	A,B,C	1G4K	0.82
CTA	CYCLOTHEONAMIDE A	A	1TYN	0.7
YTT	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	A	3G5H	0.77
CZO	[(2R,4S)-2-[(1S,2R)-1-amino-2-hydroxypropyl]-2-hydroxy-4-(4-hydroxybenzyl)-5-oxoimidazolidin-1-yl]acetic acid	A	2QRF	0.75
CCY	2-(1-AMINO-2-MERCAPTO-ETHYL)-5-(4-HYDROXY-BENZYL)-3-(ETHANOYL)-3,5-DIHYDRO-IMIDAZOL-4-ONE	A	1EMK	0.74
TYC	L-TYROSINAMIDE	A	2BF9	0.75
TYC	L-TYROSINAMIDE	A	2OCI	0.75
C27	(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one	A	2VA7	0.71
PTC	2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID	C,D	1IS0	0.71
TVN	N-{(2R)-4-(methylamino)-4-oxo-2-[4-(phosphonooxy)benzyl]butanoyl}-L-valyl-L-aspartamide	A	3C7I	0.7
GAH	N-{[(2S)-1-(N-{[4-({[AMINO(IMINO)METHYL]AMINO}METHYL)CYCLOHEXYL]CARBONYL}-3-CYCLOHEXYL-L-ALANYL)AZETIDIN-2-YL]CARBONYL}-L-TYROSYL-N~6~-[AMINO(IMINO)METHYL]-L-LYSINAMIDE	A,H	1XM1	0.72
MOY	[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE	A,B	2IEH	0.71
AOE	N-BUTYL-11-[(7R,8R,9S,13S,14S,17S)-3,17-DIHYDROXY-13-METHYL-7,8,9,11,12,13,14,15,16,17-DECAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-7-YL]-N-METHYLUNDECANAMIDE	A	1HJ1	0.73
YVN	N-({(1R,2R,3S)-2-(methylcarbamoyl)-3-[4-(phosphonooxy)phenyl]cyclopropyl}carbonyl)-L-valyl-L-aspartamide	A,B	2HUW	0.7
NLT	N-DODECANOYL-L-TYROSINE	A,B,C,D,E,F,G,H	2G0B	0.75